Marc Hasenfuss Editor-at-large

I thought it rather interesting that two of the JSE’s most vaunted "game changers" — asset manager Sygnia and day-clinics developer Advanced Health — both detailed rights issues last week.

The companies need fresh capital for (very) different reasons: Sygnia to fund the recent acquisition of db X-trackers from Deutsche Group Holdings, and Advanced to shore up its strained balance sheet to continue its day clinic roll-out.

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, Morningstar financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email or call 0860 52 52 00.